Volume 58, Issue 4, Pages (April 2013)

Slides:



Advertisements
Similar presentations
EASL Clinical Practice Guidelines: Vascular diseases of the liver Journal of Hepatology Volume 64, Issue 1, Pages (January 2016) DOI: /j.jhep
Advertisements

Omega 3 – Omega 6: What is right for the liver? Ashraf Mohammad El-Badry, Rolf Graf, Pierre-Alain Clavien Journal of Hepatology Volume 47, Issue 5, Pages.
Volume 63, Issue 1, Pages (July 2015)
Volume 46, Issue 3, Pages (March 2007)
The impact of hepatitis E in the liver transplant setting
Kirsten Boonstra, Ulrich Beuers, Cyriel Y. Ponsioen 
Inflammasomes in liver diseases
Volume 50, Issue 4, Pages (April 2009)
Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: A systematic review  Christian Thoma, Christopher P. Day, Michael.
Volume 59, Issue 6, Pages (December 2013)
Volume 68, Issue 5, Pages (May 2018)
Julien Bissonnette, Dominique Valla, Pierre-Emmanuel Rautou 
Volume 69, Issue 2, Pages (August 2018)
Volume 51, Issue 6, Pages (December 2009)
The impact of hepatitis E in the liver transplant setting
Reactive oxygen species in the normal and acutely injured liver
Cédric Coulouarn, Bruno Clément  Journal of Hepatology 
Matthew T. Kitson, Stuart K. Roberts  Journal of Hepatology 
NS5A inhibitors in the treatment of hepatitis C
Volume 42, Issue 5, Pages (May 2005)
Immigration and viral hepatitis
Volume 66, Issue 1, Pages 1-4 (January 2017)
Ype P. de Jong, Charles M. Rice, Alexander Ploss  Journal of Hepatology 
Living donor liver transplantation: is the hype over?
David G. Bowen, Christopher M. Walker  Journal of Hepatology 
Mesenchymal stromal cell therapy for liver diseases
Volume 69, Issue 2, Pages (August 2018)
Natural history and predictors of severity of chronic hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection  Anaïs Vallet-Pichard,
Jordan J. Feld, Graham R. Foster  Journal of Hepatology 
Cheng-Yuan Peng, Rong-Nan Chien, Yun-Fan Liaw  Journal of Hepatology 
Volume 69, Issue 4, Pages (October 2018)
Hepatitis C core protein – The “core” of immune deception?
Jay A. Graham, James V. Guarrera  Journal of Hepatology 
Volume 61, Issue 1, Pages S108-S119 (November 2014)
Statin use and the risk of hepatocellular carcinoma in patients at high risk: A nationwide nested case-control study  Gyuri Kim, Suk-Yong Jang, Chung.
Volume 61, Issue 1, Pages S69-S78 (November 2014)
Volume 62, Issue 3, Pages (March 2015)
Darius Moradpour, Arash Grakoui, Michael P. Manns 
Behzad Hajarizadeh, Jason Grebely, Gregory J. Dore 
Volume 62, Issue 1, Pages (January 2015)
Volume 69, Issue 4, Pages (October 2018)
EASL Clinical Practice Guidelines: Wilson’s disease
Volume 61, Issue 1, Pages S45-S57 (November 2014)
Stephen Locarnini, Angelos Hatzakis, Ding-Shinn Chen, Anna Lok 
The changing role of beta-blocker therapy in patients with cirrhosis
EASL Clinical Practice Guidelines on hepatitis E virus infection
Volume 57, Issue 5, Pages (November 2012)
Volume 50, Issue 4, Pages (April 2009)
Cédric Coulouarn, Bruno Clément  Journal of Hepatology 
Antiviral therapy for chronic hepatitis B: Challenges in Hong Kong
Paul C. Adams, James C. Barton  Journal of Hepatology 
Immigration and viral hepatitis
Clinical Practice Guidelines of the European Association for the study of the Liver – Advancing methodology but preserving practicability  Markus Cornberg,
Global burden of alcoholic liver diseases
HCV targeting of patients with cirrhosis
Volume 63, Issue 1, Pages (July 2015)
Familial amyloidosis: Great progress for an orphan disease
Volume 51, Issue 2, Pages (August 2009)
Volume 66, Issue 4, Pages (April 2017)
In This Issue Molecular Therapy Volume 16, Issue 4, (April 2008)
New trials and results in systemic treatment of HCC
Liver transplantation in children
Volume 60, Issue 6, Pages (June 2014)
Pathogenesis of cholestatic hepatitis C
Donor-recipient matching: Myths and realities
Chimeric mouse model of hepatitis B virus infection
Volume 54, Issue 6, Pages (June 2011)
Volume 50, Issue 2, Pages iii-iv (April 2019)
Reversion of disease manifestations after HCV eradication
Volume 60, Issue 6, Pages (June 2014)
Presentation transcript:

Volume 58, Issue 4, Pages 792-800 (April 2013) Clinical management of drug–drug interactions in HCV therapy: Challenges and solutions  David Burger, David Back, Peter Buggisch, Maria Buti, Antonio Craxí, Graham Foster, Hartwig Klinker, Dominique Larrey, Igor Nikitin, Stanislas Pol, Massimo Puoti, Manuel Romero-Gómez, Heiner Wedemeyer, Stefan Zeuzem  Journal of Hepatology  Volume 58, Issue 4, Pages 792-800 (April 2013) DOI: 10.1016/j.jhep.2012.10.027 Copyright © 2012 European Association for the Study of the Liver Terms and Conditions

Journal of Hepatology 2013 58, 792-800DOI: (10. 1016/j. jhep. 2012. 10 Copyright © 2012 European Association for the Study of the Liver Terms and Conditions

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.